Incidence and Predictive Risk Factors of Infective Events in Patients With Multiple Sclerosis Treated With Agents Targeting CD20 and CD52 Surface Antigens

OBJECTIVE: Monoclonal antibodies (MAbs) directed against the CD20 and CD52 antigens are used increasingly in patients with multiple sclerosis (MS). Several life-threatening opportunistic infections have been reported in postmarketing case series. The aim of this study was to investigate the incidenc...

Descripción completa

Detalles Bibliográficos
Autores principales: Zappulo, Emanuela, Buonomo, Antonio Riccardo, Saccà, Francesco, Russo, Cinzia Valeria, Scotto, Riccardo, Scalia, Giulia, Nozzolillo, Agostino, Lanzillo, Roberta, Tosone, Grazia, Gentile, Ivan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6837838/
https://www.ncbi.nlm.nih.gov/pubmed/31723572
http://dx.doi.org/10.1093/ofid/ofz445

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6837838/
https://www.ncbi.nlm.nih.gov/pubmed/31723572
http://dx.doi.org/10.1093/ofid/ofz445

Ejemplares similares